We are delighted to extend a warm greeting to you on behalf of the organizing committee for the 24th World Congress on Cancer and Diagnostics, which will be held in the vivacious city of Vancouver, Canada , on July 11-12, 2024.
Your presence at this renowned event, which promises to bring together some of the top minds in cancer research and diagnostics, makes us feel incredibly honoured and grateful. This year's conference promises to be an unrivalled chance to share your knowledge, participate in thought-provoking conversation, and learn from some of the leading experts in cancer research and diagnostics from across the world.
Vancouver, a city renowned for its inventiveness, sophistication, and gracious hospitality.
As we gather in Vancouver, we encourage you to take full advantage of the networking opportunities, engage in thought-provoking discussions, and forge lasting connections with fellow participants. Your presence and active participation are vital to making this event a resounding success.
We want to express our sincere appreciation to all of our sponsors, speakers, and participants who helped make this conference a reality. Together, we can contribute to the fight against cancer and the development of a more promising and healthy future.
The 24th World Congress on Cancer and Diagnostics is once again a pleasure to host. We are excited to embark on this amazing journey with you and wish you a personally and professionally fruitful stay in Vancouver.
Attending this conference can provide an excellent opportunity to network with colleagues and peers, share knowledge and ideas, and stay up-to-date with the latest research and developments in the field of cancer and diagnostics.
The registration and abstract submission for the upcoming World Cancer conference are now officially open!
We extend a warm invitation to you to participate and collaborate with us as an Exhibitor and Sponsor. Your involvement will be a valuable addition to the success of our event.
Important Dates
Mark your calendar and keep track of WORLD CANCER 2024 deadlines:
-
Abstract Submission Deadline: 28 June 2024 (*)
-
3rd Phase Final Registration Deadline: 28 June 2024 (*)
-
Notification of Abstract Acceptance/Rejection: 2-3 days (*)
-
World Cancer 2024 Dates: 11-12 July 2024 | Vancouver, Canada
*By Midnight-11:59 pm London Time Zone
The 24th World Congress on Cancer and Diagnostics offers a premier platform for researchers, clinicians, industry professionals, and policymakers to convene, collaborate, and catalyze advancements in the fight against cancer. Set against the backdrop of picturesque Vancouver, Canada, this conference promises to be a pivotal event in shaping the future of cancer research and diagnostics.
Top Reasons to Attend:
-
Cutting-Edge Research Presentations: Immerse yourself in a comprehensive program featuring presentations from leading experts in the field of oncology and diagnostics.
-
Networking Opportunities: Connect with a diverse community of professionals including researchers, clinicians, industry leaders, and policymakers.
-
Interactive Workshops and Symposia: Engage in interactive workshops and symposia designed to deepen your understanding of key topics such as precision medicine, immunotherapy, early detection strategies, and emerging technologies in cancer diagnostics.
-
Poster Presentations: Showcase your own research findings through poster presentations and receive valuable feedback from peers and experts in the field.
-
Industry Insights and Exhibits: Explore the latest advancements in cancer diagnostics, therapeutics, and technology through exhibits and presentations by leading industry partners.
-
Continuing Education Credits: Earn valuable continuing education credits by attending accredited sessions led by esteemed professionals.
-
Global Perspective: Gain a global perspective on cancer research and diagnostics by interacting with participants from around the world. Learn about regional challenges, innovative approaches, and best practices that can inform and enrich your own work.
-
Inspiration and Motivation: Be inspired by keynote speeches, panel discussions, and success stories from individuals who are at the forefront of cancer research and diagnostics.
The 24th World Congress on Cancer and Diagnostics is a prestigious gathering that welcomes a diverse array of professionals from various disciplines within the realm of Oncology and diagnostics.
Here's a comprehensive guide on who can benefit from attending this esteemed event in Vancouver, Canada, on July 11-12, 2024.
1. Researchers: Leading researchers in the fields of oncology, molecular biology, genetics, pathology, and related disciplines are encouraged to attend. Whether you're a seasoned investigator or an early-career scientist, this conference offers a platform to showcase your latest findings, engage in stimulating discussions, and forge collaborations with like-minded peers.
2. Clinicians: Oncologists, hematologists, radiologists, pathologists, surgeons, and other healthcare professionals involved in cancer diagnosis, treatment, and patient care will find immense value in attending.
3. Industry Professionals: Representatives from pharmaceutical companies, biotechnology firms, medical device manufacturers, and diagnostic laboratories are encouraged to participate.
4. Academicians and Educators: Faculty members, educators, and academic researchers involved in cancer education and training programs will find the conference enriching.
5. Policy Makers and Regulators: Government officials, policymakers, regulatory agencies, and representatives from health organizations are invited to participate in discussions related to healthcare policy, regulatory frameworks, and public health initiatives in cancer prevention, screening, and treatment.
6. Students and Trainees: Undergraduate and graduate students, postdoctoral fellows, residents, and trainees interested in pursuing careers in cancer research, diagnostics, or clinical practice are encouraged to attend.
7. Patient Advocates and Support Groups: Patient advocates, caregivers, and representatives from cancer support organizations play a crucial role in shaping the cancer care landscape.
The 24th World Congress on Cancer and Diagnostics (World Cancer 2024) offers a comprehensive program featuring a wide range of sessions and tracks focusing on the latest advancements and challenges in the field of Oncology. The conference aims to provide a platform for experts, researchers, and practitioners to exchange knowledge, discuss emerging trends, and explore innovative approaches to improving the diagnosis and treatment of Cancer.
Key Sessions & Tracks:
1. Early Detection and Screening : The "Early Detection and Screening" session at the 24th World Congress on Cancer and Diagnostics is a cornerstone of the event, focusing on advancements in identifying cancer at its earliest stages. This session brings together experts from various disciplines to explore cutting-edge methodologies, technologies, and strategies aimed at improving early detection and screening protocols.
2. Breast Cancer : The "Breast Cancer" session at the 24th World Congress on Cancer and Diagnostics is dedicated to advancing our understanding of breast cancer, one of the most prevalent and impactful cancers affecting individuals worldwide. This session serves as a platform for researchers, clinicians, and industry professionals to exchange knowledge, share insights, and collaborate on innovative approaches to breast cancer prevention, diagnosis, and treatment.
3. Cancer Prevention :The "Cancer Prevention" session at the 24th World Congress on Cancer and Diagnostics is a pivotal forum for exploring strategies to reduce the global burden of cancer through prevention initiatives. This session will bring together leading experts, researchers, clinicians, policymakers, and advocates to discuss innovative approaches, evidence-based interventions, and public health policies aimed at reducing the incidence of cancer and promoting healthy lifestyles.
4. Cancer Therapies : The "Cancer Therapies" session at the 24th World Congress on Cancer and Diagnostics is a cornerstone of the conference, focusing on the latest advancements in cancer treatment modalities and therapeutic approaches. This session provides a comprehensive platform for researchers, clinicians, industry professionals, and policymakers to exchange knowledge, share insights, and discuss emerging trends in cancer therapy.
Treatments include: surgery – an operation to remove the cancer is the main treatment for many types of cancer. radiotherapy – high energy X-rays are used to destroy the cancer cells. chemotherapy – uses anti-cancer (cytotoxic) drugs to destroy cancer cells.
5. Cancer Immunology and Immunotherapy : The "Cancer Immunology and Immunotherapy" session at the 24th World Congress on Cancer and Diagnostics is dedicated to exploring the dynamic interplay between the immune system and cancer, as well as the revolutionary advancements in harnessing the immune system to combat cancer. Topics will include Tumor Microenvironment (TME) Dynamics,Immune Checkpoint Pathways and Blockade,Adoptive Cell Therapies (ACT),Cancer Vaccines and Therapeutic Antibodies,Combination Immunotherapy Approaches,Emerging Immunotherapeutic Targets and Strategies.
6. Cancer Syndrome : The "Cancer Syndromes" session at the 24th World Congress on Cancer and Diagnostics is dedicated to unraveling the complexities of inherited and familial cancer predisposition syndromes. This session will bring together experts from various disciplines to explore the genetic, molecular, and clinical aspects of cancer syndromes, as well as advancements in diagnosis, management, and genetic counseling. Topics will be covered Hereditary Cancer Syndromes,Genetic Testing and Counseling,Clinical Manifestations and Screening Guidelines,Precision Medicine Approaches,Psychosocial and Ethical Considerations,Future Directions and Challenges.
7. Cancer Genomics : The "Cancer Genomics" session at the 24th World Congress on Cancer and Diagnostics is dedicated to unraveling the genomic landscape of cancer and its implications for diagnosis, prognosis, and treatment. This session includes key topics like Genomic Alterations in Cancer,Genomic Profiling Technologies,Precision Oncology Approaches,Liquid Biopsies and Circulating Biomarkers,Cancer Genomics Data Analysis,Clinical Translation and Challenges
8. Cancer and Nanotechnology : The "Cancer and Nanotechnology" session at the 24th World Congress on Cancer and Diagnostics is dedicated to exploring the transformative potential of nanotechnology in cancer diagnosis, treatment, and theranostics. This session will bring together experts from diverse disciplines to discuss cutting-edge research, innovative nanotechnologies, and their applications in addressing key challenges in cancer management.
9. Cancer Drug Development :The "Cancer Drug Development" session at the 24th World Congress on Cancer and Diagnostics is dedicated to exploring the latest advancements, challenges, and opportunities in the development of novel cancer therapeutics. This session will bring together leading researchers, clinicians, pharmaceutical industry professionals, and regulatory experts to discuss innovative approaches, emerging trends, and translational strategies in cancer drug discovery and development. The key Topics covered for this sessions are Target Identification and Validation,Drug Design and Optimization,Preclinical Models and Translational Research,Clinical Trial Design and Biomarker Development,Combination Therapies and Resistance Mechanisms,Regulatory Considerations and Market Access
10. Cancer Biopsy :The "Cancer Biopsy" session at the 24th World Congress on Cancer and Diagnostics is dedicated to exploring the role of biopsy procedures in cancer diagnosis, prognosis, and personalized treatment decision-making. This session will bring together experts in oncology, pathology, radiology, and interventional medicine to discuss the latest advancements, challenges, and best practices in cancer biopsy techniques and interpretation.
11. Diagnostic and Imagination of Radiation :The "Diagnostic and Imaging Radiation" session at the 24th World Congress on Cancer and Diagnostics is dedicated to exploring the latest advancements, techniques, and safety considerations in medical imaging utilizing radiation. This session will gather experts from radiology, oncology, medical physics, and radiation safety to discuss innovations, best practices, and emerging technologies in diagnostic imaging for cancer detection, staging, and treatment monitoring.
12. Lung Cancer : The "Lung Cancer" session at the 24th World Congress on Cancer and Diagnostics serves as a focal point for addressing the complexities of lung cancer, a leading cause of cancer-related morbidity and mortality worldwide. This session convenes experts from various disciplines to discuss advancements in prevention, early detection, diagnosis, treatment, and supportive care for lung cancer patients.
13. Oncology Biomarkers :The "Oncology Biomarkers" session at the 24th World Congress on Cancer and Diagnostics is dedicated to exploring the role of biomarkers in cancer diagnosis, prognosis, treatment selection, and monitoring. This session will bring together experts from oncology, molecular biology, bioinformatics, and clinical research to discuss the latest advancements, challenges, and opportunities in biomarker discovery and validation for various cancer types.
14. Pediatric Cancer : The "Pediatric Cancer" session at the 24th World Congress on Cancer and Diagnostics is dedicated to addressing the unique challenges and advancements in the diagnosis, treatment, and care of pediatric oncology patients. This session will bring together experts from various disciplines to discuss the latest research, innovations, and collaborative efforts aimed at improving outcomes for children and adolescents with cancer.
15. Psycho Oncology : The "Psycho-Oncology" session at the 24th World Congress on Cancer and Diagnostics is dedicated to understanding the psychological, social, and emotional aspects of cancer diagnosis, treatment, survivorship, and end-of-life care. This session will bring together experts from psychology, psychiatry, oncology, social work, and palliative care to discuss the impact of cancer on patients, families, and caregivers, as well as strategies for addressing psychosocial needs and enhancing quality of life throughout the cancer journey.
Participant Options & Benefits
World Cancer 2024 offers participants a range of options to engage with the conference and maximize their experience:
-
Full Conference Attendance: Participants can attend all sessions, including plenary talks, panel discussions, workshops, and poster presentations, gaining comprehensive insights into the latest advancements in Oncology.
-
Virtual Attendance: For those unable to travel, virtual attendance options are available, providing access to live-streamed sessions and the opportunity to engage with speakers and attendees remotely.
-
Poster Presentation: Researchers and professionals can present their work through poster presentations, sharing their findings and receiving feedback from peers and experts.
-
Networking Opportunities: The conference provides ample networking opportunities, allowing participants to connect with leading experts, researchers, and professionals in the field of Cancer and Diagnostics.
-
Access to Resources: Participants will have access to conference materials, including abstracts, presentations, and recorded sessions, enabling them to review key learnings and share them with colleagues.
-
Professional Development: Attendees can enhance their professional development by staying updated on the latest trends, technologies, and best practices in Oncology.
-
Collaboration Opportunities: The conference fosters collaboration and knowledge exchange, providing a platform for participants to collaborate on future research projects and initiatives.
World Cancer 2024 offers a unique opportunity for professionals in the field of Oncology to enhance their knowledge, network with peers, and contribute to the advancement of the field.
-
American Association for Cancer Research (AACR): AACR is a prominent organization committed to accelerating cancer research and improving patient outcomes. By collaborating with AACR, the World Congress gains access to cutting-edge research, expert insights, and a network of professionals driving progress in the field.
-
European Society for Medical Oncology (ESMO): ESMO is a leading European organization dedicated to advancing medical oncology and multidisciplinary cancer care. Collaboration with ESMO enriches the scientific program of the World Congress and fosters international collaboration among oncology professionals.
-
International Society for Biological and Environmental Repositories (ISBER): ISBER is a global society focused on advancing biobanking and biospecimen research. Affiliation with ISBER brings expertise in biospecimen management and ethical standards to the conference, enhancing discussions on biobanking infrastructure and data sharing.
-
World Health Organization (WHO): WHO plays a crucial role in coordinating global efforts to prevent, control, and treat cancer. Collaboration with WHO provides access to evidence-based guidelines and initiatives aimed at reducing the global cancer burden.
-
Canadian Cancer Society (CCS): CCS is a national charitable organization dedicated to funding cancer research, providing support services, and advocating for policy changes. Affiliation with CCS strengthens connections with the Canadian oncology community and enhances the local relevance of the conference.
-
International Agency for Research on Cancer (IARC): IARC conducts research on the causes and prevention of cancer worldwide. Collaboration with IARC brings expertise in cancer epidemiology and population-based interventions to the conference.
The 24th World Cancer and Diagnostics Conference, scheduled to take place on July 11-12, 2024, in Vancouver, Canada, presents a significant opportunity within the global oncology and diagnostics market. Here's a comprehensive market analysis:
-
Growth Trends in Oncology and Diagnostics Market: The global oncology market is witnessing robust growth, driven by factors such as increasing cancer incidence, advancements in diagnostic technologies, and a growing emphasis on personalized medicine. The diagnostics market is also expanding rapidly, with innovations in imaging, molecular diagnostics, and biomarker testing driving market growth.
-
Market Size and Potential: The oncology market is projected to reach USD 285.5 billion by 2026, with a compound annual growth rate (CAGR) of 11.6% from 2021 to 2026. The diagnostics market is expected to surpass USD 100 billion by 2025. With the increasing demand for cancer diagnosis, treatment, and monitoring, the World Cancer and Diagnostics Conference is well-positioned to attract a diverse audience of healthcare professionals, researchers, industry experts, and policymakers.
-
Key Players and Stakeholders: Major players in the oncology and diagnostics market include pharmaceutical companies, medical device manufacturers, diagnostic laboratories, academic institutions, and government agencies. These stakeholders play a crucial role in driving innovation, funding research, and shaping healthcare policies related to cancer care and diagnostics.
-
Emerging Trends and Opportunities: The conference provides a platform to explore emerging trends such as precision medicine, liquid biopsy, immunotherapy, and artificial intelligence in oncology and diagnostics. Attendees can expect to gain insights into the latest advancements, exchange best practices, and explore collaboration opportunities to address unmet needs in cancer detection, treatment, and patient care.
-
Regional Dynamics: Vancouver, Canada, serves as an ideal location for the conference, given its strong healthcare infrastructure, research capabilities, and commitment to oncology innovation. Canada boasts a robust healthcare system and is home to leading cancer research institutions and biotechnology companies, making it an attractive destination for stakeholders in the oncology and diagnostics market.
Overall, the 24th World Cancer and Diagnostics Conference presents a prime opportunity for stakeholders to stay abreast of the latest developments, foster collaborations, and contribute to advancing the field of oncology and diagnostics on a global scale.
World Cancer 2023 Report:
Conference Series hosted the event “23nd World Congress on Cancer and Diagnostics” at Toronto, Canada on August 23-24, 2023 The conferences were organized with a focus on the themes “Explore the Recent Innovative Treatment & Diagnostic of Oncology” was a great success where eminent keynote speakers from various reputed companies and Universities made their resplendent presence and addressed the gathering.
The event proceedings were carried out through several Scientific-sessions and plenary lectures, Conference Series would like to express a sincere thankfulness to all the Honourable guests and Keynote Speakers 23nd World Congress on Cancer and Diagnostics”.
World Cancer 2023 committee would like to convey a warm gratitude to all the Honorable guests and Keynote Speakers Kim Jaffee from Wayne State University USA, Maria Bourazani from Agios Savvas - Anticancer Hospital Greece, Maude Hebert from University of Quebec in Trois-Rivieres Canada, Guan Chen Medical College of Wisconsin USA, Marco Bernini from Careggi University Hospital, Florence Italy, Kim Jaffee from Wayne State University USA have given a wonderful talk which makes allows the delegates and other attendees to gain the knowledge about main course of the event.
World Cancer 2023 Organizing Committee would like to thank the Moderator of the conference, Julie Benoit from Institut de Formation en Soins Infirmiers, France, who contributed a lot for the smooth functioning of this event and for taking up the responsibility to coordinate during the sessions for smooth functioning of this event. We are indebted to your support.
Conference Series conferences also took the privilege of World Cancer 2023 Organizing Committee, Keynote Speakers, Plenary Speakers, Chairs and Co-Chairs, Young Researchers and other attendees whose support made the conference a great success.
We are very glad to have shared a great relationship with all these Attendees, associations and we hope to see even greater support in our upcoming events. We would also like to thank Chairs and Co-chairs of the conference, Dr. El Hadji Seydou from BCNet International Working Group, Lyon (France); Jamal Khader from King Hussein Cancer Center from Amman, Jordan; for a being a great support for our event to be a grand success.
Save your dates for the most awaited event of 2024
With a great response and feedback which we received from participants and supporters from World Cancer 2023, we are proud to announce our upcoming conferences in the Series World Cancer 2024 on July 11-12, 2024 in Vancouver, Canada with the theme of the event is “Building Bridges to Overcome Cancer-Free World”.
The centre of the activity of World Cancer 2024 is to produce the clear visual definition by undergoing with Oral Presentation, Poster presentation, Workshop, Exhibition, networking and interacting session.
With the feedback from your renowned Speakers, we have added some of the new Session tracks that needs to be focused such as such as Tissue Regeneration and Cancer, Cancer Syndrome, Artificial Intelligence and Oncology, Cancer Immunology and Immunotherapy, Cancer Therapies, Cancer Screening, Pediatric Cancer in Oncology and related research, Cancer Immunology.With the great support we have successfully completed World Cancer 2023 and we are expecting huge response and support from the Oncology and Diagnosis Doctors, Professionals, Young researchers, Students, Delegates, Directors and other related companies to have your gracious presence at World Cancer 2024 on July 11-12, 2024 in Vancouver, Canada to make this congress a great successful event of the year 2024
Join our team World Cancer 2024 at this beautiful city of Vancouver and let’s make this professional gathering a Great success
Contact us:
Eva Wilson
Program Manager
World Cancer 2024
Dr Saifee Abbas Mullamitha
Eric E. Kelley
Jennie R Lill
Prof. Dr. Dimos Baltas 
Dr Omar Khan
Prof. Dr. Anca-Ligia Grosu 
Dr Rachel Dultz
Kai Fu Tang
Orestis Ioannidis
Chunyang Jiang
Mujib Ullah
